Styczynski J - Search Results

1

Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.

Gil L, Styczynski J, Komarnicki M. Gil L, et al. Among authors: styczynski j. Infection. 2007 Dec;35(6):421-7. doi: 10.1007/s15010-007-6350-2. Epub 2007 Oct 9. Infection. 2007. PMID: 17926001

2

Risk of HCV infections among children with cancer and health-care workers in children's hospitals.

Styczynski J, Koltan S, Wysocki M, Graczykowski R, Narolska E, Balcar-Boron A. Styczynski J, et al. Infection. 1999 Jan-Feb;27(1):36-8. doi: 10.1007/BF02565169. Infection. 1999. PMID: 10027105

3

A nine-year experience of immunoprophylaxis against hepatitis B virus infection in children with cancer: results from a single institution in Poland.

Styczynski J, Wysocki M, Koltan S, Kurylak A. Styczynski J, et al. J Hosp Infect. 2001 Aug;48(4):298-303. doi: 10.1053/jhin.2001.1017. J Hosp Infect. 2001. PMID: 11461131

4

In vitro drug resistance profiles of adult acute lymphoblastic leukemia: possible explanation for difference in outcome to similar therapeutic regimens.

Styczynski J, Wysocki M. Styczynski J, et al. Leuk Lymphoma. 2002 Feb;43(2):301-7. doi: 10.1080/10428190290006071. Leuk Lymphoma. 2002. PMID: 11999561

5

In vitro comparative antileukemic activity of various glucocorticoids in childhood acute leukemia.

Styczyński J, Wysocki M, Balwierz W, Rokicka-Milewska R, Matysiak M, Balcerska A, Kowalczyk A, Wachowiak J, Sońta-Jakimczyk D, Chybicka A. Styczyński J, et al. Neoplasma. 2002;49(3):178-83. Neoplasma. 2002. PMID: 12098004

6

Cross-resistance to five glucocorticoids in childhood acute lymphoblastic and non-lymphoblastic leukemia samples tested by the MTT assay: preliminary report.

Styczyński J, Wysocki M, Debski R, Balwierz W, Rokicka-Milewska R, Matysiak M, Balcerska A, Kowalczyk J, Wachowiak J, Sońta-Jakimczyk D, Chybicka A. Styczyński J, et al. Acta Biochim Pol. 2002;49(1):93-8. Acta Biochim Pol. 2002. PMID: 12136961 Free article.

7

Ex vivo drug resistance profile in childhood acute myelogenous leukemia: no drug is more effective in comparison to acute lymphoblastic leukemia.

Styczynski J, Wysocki M, Debski R, Juraszewska E, Malinowska I, Stanczak E, Ploszynska A, Stefaniak J, Mazur B, Szczepanski T. Styczynski J, et al. Leuk Lymphoma. 2002 Sep;43(9):1843-8. doi: 10.1080/1042819021000006394. Leuk Lymphoma. 2002. PMID: 12685842

8

Differences in significance of drug resistance mechanisms between adult and childhood acute lymphoblastic leukemia.

Styczyński J, Wysocki M. Styczyński J, et al. Haematologia (Budap). 2002;32(4):313-25. Haematologia (Budap). 2002. PMID: 12803106 Review.

9

Ex vivo drug resistance in childhood acute myeloid leukemia on relapse is not higher than at first diagnosis.

Styczynski J, Wysocki M. Styczynski J, et al. Pediatr Blood Cancer. 2004 Feb;42(2):195-9. doi: 10.1002/pbc.10457. Pediatr Blood Cancer. 2004. PMID: 14752887

10

Decrease of dual hepatitis B and C virus infections in children with cancer: changes in risk factors over 30 years.

Koltan S, Styczynski J, Wysocki M, Koltan A, Kurylak A, Debski R. Koltan S, et al. Among authors: styczynski j. Haematologica. 2004 Feb;89(2):251-2. Haematologica. 2004. PMID: 15003909 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results